Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib
Publisher： John Wiley & Sons Inc
E-ISSN： 1582-4934|22|2|1070-1080
ISSN： 1582-1838
Source： Journal of Cellular and Molecular Medicine, Vol.22, Iss.2, 2018-02, pp. : 1070-1080
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
